Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2010
10/05/2010US7807197 Composite dosage forms having an inlaid portion
10/05/2010US7807196 Using inert gas; controlling humidity
10/05/2010US7807195 Extended release formulation of venlafaxine hydrochloride
10/05/2010US7807194 Plasticizer, film former, bulking agent, and pH controlling agent;
10/05/2010US7807193 Method of treating insulin resistance, adult onset diabetes and metabolic syndrome X
10/05/2010US7807191 Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
10/05/2010US7807189 formulations administered in bath or shower, depositing thin layer of moisturizing agents on application, which is not rinsed off but remains to protect skin from drying; results in soft skin feel; formulations comprise polyvalent metal cations and fatty acids which react to form insoluble salts
10/05/2010US7807188 physiologically compatible composition containing hydrated synthetic cells in a lipid matrix in an amount effective to treat skin
10/05/2010US7807187 Endogenous adjuvant molecules and uses thereof
10/05/2010US7807185 applying to skin or mucous membrane of a mammal a composition comprising an extracellular product of a Pseudomonas lindbergii strain, an extracellular product of a Bacillus coagulans strain, and an anti-fungal agent selected from Amphotericin B, Carbol-Fuchsin, Ciclopirox, for example
10/05/2010US7807169 Stratified and cryogenically stored vaccines, process for their preparation
10/05/2010US7807151 identifying a mammalian subject having an infection with said pathogenic Clostridium bacterium resistant to antibiotic, orally administering a therapeutically-effective concentration of Bacillus coagulans bacteria
10/05/2010US7807142 comprising interleukin-2 (IL-2); using an amino acid base sufficient to decrease aggregate formation of the polypeptide during storage of the composition, and a buffering agent ; mixture with amino acid and buffer
10/05/2010US7807125 wet granulation process for preparing calcium carbonate granulation comprising mixing in high shear mixer a powdered calcium carbonate having median particle diameter from 6-12 mu m, maltodextrin and optionally additional excipients, adding water, convection drying in horizontal fluidized bed oven
10/05/2010US7806876 Implantable vascular access device
10/05/2010US7806853 Array and method for dosing a hormone regulating blood sugar in a patient
10/05/2010US7806749 Cosmetic appliance and method of use
10/05/2010CA2611418C Medicament carrier composition and method of forming a film therefrom
10/05/2010CA2559023C Compositions with health and nutrition promoting characteristics, containing interesterified lipids and phytosterol, and related methods
10/05/2010CA2473450C Multifunctional particulate material, fluid, and composition
10/05/2010CA2455167C New pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
10/05/2010CA2452638C Optimised formulation of tobramycin for aerosolization
10/05/2010CA2431705C Method for preparing submicron particle suspensions
10/05/2010CA2425218C Pharmaceutical solutions of modafinil compounds
10/05/2010CA2393297C Polyhydroxystilbenes as antipsoriatic agents and protein kinase inhibitors
10/05/2010CA2370784C Endodontic fibers and methods of use therefor
10/05/2010CA2369595C Conjugate having a cleavable linkage for use in a liposome
10/05/2010CA2361951C Process for producing a powder containing crystalline particles of maltitol
10/05/2010CA2331744C Aloe pectins
10/05/2010CA2322516C Sustained release macrolide compositions
09/2010
09/30/2010WO2010111680A2 Dry powder formulations and methods for treating pulmonary diseases
09/30/2010WO2010111652A2 Branched amphipathic oligo-peptides that self-assemble into vesicles
09/30/2010WO2010111650A2 Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining
09/30/2010WO2010111644A1 Pharmaceutical formulations and methods for treating respiratory tract infections
09/30/2010WO2010111641A2 Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis
09/30/2010WO2010111640A2 Anti-influenza formulations and methods
09/30/2010WO2010111627A1 Implantable formulations of bisphosphonic acids
09/30/2010WO2010111620A1 Ascorbate-linked nanosystems for brain delivery
09/30/2010WO2010111511A1 Binary and tertiary galvanic particulates and methods of manufacturing and use thereof
09/30/2010WO2010111487A1 Method and composition for alleviating or preventing ischemic tissue damage
09/30/2010WO2010111449A1 Intraocular sustained release drug delivery systems and methods for treating ocular conditions
09/30/2010WO2010111403A2 Probablistic pharmacokinetic and pharmacodynamic modeling
09/30/2010WO2010111397A1 Stabilized solubility-enhanced formulations for oral delivery
09/30/2010WO2010111271A1 Orally bioavailable lipid-based constructs
09/30/2010WO2010111264A2 Rasagiline formulations
09/30/2010WO2010111221A2 Compositions and methods for preferential distribution of active agents to injury sites
09/30/2010WO2010111215A2 Compositions and methods for treatment of hemorrhage
09/30/2010WO2010111184A1 Device to deliver magnesium in peg formulation
09/30/2010WO2010111178A2 Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
09/30/2010WO2010111172A1 Methods of treatment using combination therapy
09/30/2010WO2010111115A1 Method for preparing suspensions of low-solubility materials
09/30/2010WO2010110471A1 Lipid membrane structure
09/30/2010WO2010110322A1 Solid preparation
09/30/2010WO2010110321A1 Adhesion preventing composition, solid preparation and method for producing same
09/30/2010WO2010110320A1 Solid preparation
09/30/2010WO2010110318A1 Therapeutic agent for arteriosclerotic diseases comprising nucleic acid
09/30/2010WO2010110314A1 Therapeutic agent for pulmonary hypertension comprising nucleic acid
09/30/2010WO2010110220A1 Dispersion and manufacturing method therefor
09/30/2010WO2010110118A1 Method for producing liposomes
09/30/2010WO2010110116A1 Method for producing liposomes by two-stage emulsification using nano-sized primarily emulsified product
09/30/2010WO2010110018A1 Coated solid preparation
09/30/2010WO2010109961A1 Burdock fruit extract containing arctigenin at high content and process for producing same
09/30/2010WO2010109913A1 Transdermal preparation
09/30/2010WO2010109544A1 Composition for external application containing nucleic acid as active ingredient
09/30/2010WO2010109475A1 A sustained release oral composition of an antipsychotic agent
09/30/2010WO2010109434A2 A medicinal antibacterial, antifungal and steroids cream and a process to make it
09/30/2010WO2010109433A1 An antiviral medicinal cream and a process to make it
09/30/2010WO2010109432A1 An antiscabies medicinal cream and a process to make it
09/30/2010WO2010109425A2 A medicinal steroids cream and a process to make it
09/30/2010WO2010109424A1 A medicinal antibacterial and steroids cream comprising chitosan and a process to make it
09/30/2010WO2010109423A1 A medicinal antifungal and steroids cream comprising chitosan and a process to make it
09/30/2010WO2010109422A1 A medicinal cream for diaper rash and a process to make it
09/30/2010WO2010109421A1 A medicinal antifungal and steroids cream comprising chitosan and a process to make it
09/30/2010WO2010109420A1 A medicinal anti acne cream comprising chitosan and a process to make it
09/30/2010WO2010109418A1 A medicinal antifungal cream and a process to make it
09/30/2010WO2010109417A1 A medicinal antibacterial cream and a process to make it
09/30/2010WO2010109330A2 Cholesterol level lowering liposomes
09/30/2010WO2010109259A1 Method for preparing soft gel formulations of liquid isotretinoin and formulations obtained
09/30/2010WO2010109180A1 Composition for the administration of polymeric drugs
09/30/2010WO2010109176A2 Composition for use in gene therapy
09/30/2010WO2010109019A1 Orodispersible tablets
09/30/2010WO2010108934A1 Pharmaceutical composition containing a drug and sirna
09/30/2010WO2010108845A1 Pharmaceutical composition containing levodopa, entacapone and carbidopa
09/30/2010WO2010108683A1 Use of date syrup as a binder
09/30/2010WO2010108553A1 Compositions and pharmaceutical forms for the oral administration of thyroid hormones able to combat the action of sequestrants in the gastrointestinal tract
09/30/2010WO2010108408A1 Composition of traditional chinese medicine for reducing blood fat and preparation method thereof
09/30/2010WO2010093285A8 Composition comprising biodegradable carrier for controlled drug delivery
09/30/2010WO2010071320A3 Controlled-release composition for producing sustained-release preparation containing udenafil
09/30/2010WO2010055477A3 Cell piercing device and method of using the same
09/30/2010WO2009139504A3 A solid pharmaceutical formulation
09/30/2010WO2009108554A3 System for delivery of protein in insoluble fibrillar or aggregate form
09/30/2010US20100249924 Bioerodible matrix for tissue involvement
09/30/2010US20100249757 Method of Electrogenically Controlling Pump Molecules
09/30/2010US20100249746 Drug delivery system for accelerated subcutaneous absorption
09/30/2010US20100249240 Synergistic mixed poloxamer systems for the solubilisation of drugs
09/30/2010US20100249237 Non-Steroidal Anti-Inflammatory Drug Dosing Regimen
09/30/2010US20100249218 Method to inhibit cell growth using oligonucleotides
09/30/2010US20100249150 Stable pharmaceutical composition of freeze-dried tetrodoxin powder
09/30/2010US20100247737 Method for producing granulated preparation
09/30/2010US20100247689 Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue
1 ... 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 ... 2991